AKT1 and neoplasm: The Th2 marker cytokine IL-4 promoted the proliferation of human pancreatic cancer cells and enhanced the activation of STAT3, AKT, and MAPK pathways [151], suggesting direct tumor-promoting activity (Figure 4).